Sula Mazimba Selected Research

LY 165163 (PAPP)

9/2021	Pulmonary Artery Proportional Pulse Pressure (PAPP) Index Identifies Patients With Improved Survival From the CardioMEMS Implantable Pulmonary Artery Pressure Monitor.
11/2017	Decreased pulmonary arterial proportional pulse pressure is associated with increased mortality in group 1 pulmonary hypertension.
12/2016	Decreased Pulmonary Arterial Proportional Pulse Pressure After Pulmonary Artery Catheter Optimization for Advanced Heart Failure Is Associated With Adverse Clinical Outcomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sula Mazimba Research Topics

Disease

14	Heart Failure 10/2022 - 12/2010
3	Hemorrhage 11/2020 - 12/2019
2	Cardiomyopathies (Cardiomyopathy) 03/2022 - 12/2010
2	Atrial Fibrillation 01/2022 - 09/2020
2	Cicatrix (Scar) 01/2022 - 12/2021
2	Pulmonary Hypertension 09/2021 - 11/2017
2	Pulmonary Arterial Hypertension 10/2020 - 04/2019
2	Hypertension (High Blood Pressure) 01/2020 - 01/2019
1	Gout 07/2022
1	Schistosomiasis (Bilharziasis) 04/2022
1	Pulmonary Embolism 01/2022
1	High Cardiac Output 01/2020
1	Primary Graft Dysfunction 12/2019
1	Inflammation (Inflammations) 12/2019
1	Inferior Wall Myocardial Infarction 05/2019
1	Airway Obstruction (Choking) 01/2019
1	Pulmonary Edema 01/2019
1	Apnea 01/2019
1	Cardiogenic Shock 11/2018
1	Stroke (Strokes) 01/2018
1	Familial Primary Pulmonary Hypertension 11/2017
1	Infections 09/2014
1	Neoplasms (Cancer) 12/2010
1	Heart Diseases (Heart Disease) 12/2010
1	Cardiac Arrhythmias (Arrythmia) 12/2010
1	Cardiotoxicity 12/2010
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2010
1	Multiple Myeloma 12/2010

Drug/Important Bio-Agent (IBA)

3	LY 165163 (PAPP)IBA 09/2021 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2019
2	Oxygen (Dioxygen)IBA 10/2020 - 01/2019
1	Colchicine FDA LinkGeneric 07/2022
1	Anti-Arrhythmia AgentsIBA 03/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Natriuretic PeptidesIBA 01/2022
1	PlasticsIBA 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	AntigensIBA 01/2020
1	Prostaglandins DIBA 12/2019
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 04/2019
1	CatecholaminesIBA 01/2019
1	Pharmaceutical PreparationsIBA 12/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2010
1	AnthracyclinesIBA 12/2010
1	UbiquitinIBA 12/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2010
1	Bortezomib (Velcade)FDA Link 12/2010
1	Trastuzumab (Herceptin)FDA Link 12/2010
1	Proteasome InhibitorsIBA 12/2010

Therapy/Procedure

7	Therapeutics 10/2022 - 12/2010
4	Heart Transplantation (Grafting, Heart) 11/2020 - 09/2014
4	Heart-Assist Devices 12/2019 - 12/2016
2	Catheters 10/2022 - 12/2016
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2019
2	Cardiac Resynchronization Therapy 12/2021 - 12/2020
2	Patient Readmission 12/2020 - 12/2016
2	Length of Stay 06/2020 - 12/2019
1	Extracorporeal Membrane Oxygenation 01/2022
1	Defibrillators (Defibrillator) 12/2020
1	Stents 11/2020
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2020
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Hospital to Home Transition 03/2019
1	Perioperative Care 01/2019
1	Transplantation 12/2016